This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignees: Hankang Biochemical & Pharmaceutical Co., Ltd, Shandong Xinchuang Biotechnology Co., Ltd.. Active years: 2017-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
1 out of 2 Years Active: 2017-2019
Title: Innovations and Contributions of Inventor Hong Meng
Introduction
Hong Meng is a notable inventor based in Jinan, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative treatments for cancer and bacterial infections. With a total of 2 patents, his work showcases a commitment to advancing medical science.
Latest Patents
Hong Meng's latest patents include groundbreaking applications in the treatment of non-small cell lung carcinoma. One of his notable inventions is the application of derivatives of clostridium ghonii, specifically the MW-DCG-HNCv-18 strain. This strain has demonstrated a specific inhibition effect on non-small cell lung carcinoma, significantly surpassing the efficacy of other known strains. Furthermore, his research reveals that when combined with Docetaxel, the MW-DCG-HNCv-18 strain exhibits an even more pronounced inhibition effect. Another significant patent involves a pharmaceutical composition that combines honeysuckle extract containing iridoid compounds with antibiotics. This composition aims to improve the responsiveness of multi-drug resistant bacteria to antibiotics, presenting a promising clinical application for treating refractory bacterial infections.
Career Highlights
Throughout his career, Hong Meng has worked with several prominent companies, including Shandong Xinchuang Biotechnology Co., Ltd. and Hankang Biochemical & Pharmaceutical Co., Ltd. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to the advancement of pharmaceutical technologies.
Collaborations
Hong Meng has collaborated with notable colleagues such as Laitian Xing and Yong Wang. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his inventions.
Conclusion
In summary, Hong Meng is a distinguished inventor whose work in pharmaceuticals has the potential to transform treatment options for cancer and bacterial infections. His innovative patents reflect a deep understanding of medical challenges and a dedication to finding effective solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile